Nontoxic genetic engineering of mesenchymal stem cells using serum-compatible pullulan-spermine/DNA anioplexes

Tissue Engineering - Part C: Methods

Volumn 17, Issue 2, 2011, Pages 131-144

  Thakor, Devang K ^a,b,c   Teng, Yang D ^b,c   Obata, Hideaki ^d   Nagane, Kentaro ^a   Saito, Shigeru ^d   Tabata, Yasuhiko ^a  

^a KYOTO UNIVERSITY   (Japan)

^b VA BOSTON HEALTHCARE SYSTEM   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d GUNMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BODY FLUIDS; FLOWCHARTING; GENE TRANSFER; GENES; STEM CELLS;

ADIPOGENIC; BIOLOGICAL INERTNESS; BIOLOGICAL PROPERTIES; CATIONIC LIPIDS; CHONDROGENIC; ENGRAFTMENT; GENE CARRIER; GENETIC MODIFICATIONS; GROWTH MEDIUM; IN-VIVO; INTRATHECAL; LIPOFECTION; MESENCHYMAL STEM CELL; MINIMALLY INVASIVE; NATURAL POLYSACCHARIDE; NEUROPATHIC PAIN; OSTEOGENIC; PELLET FORMATION; POLYAMINES; PULLULANS; RAT SPINAL CORD; REPORTER GENE; SERUM-FREE CONDITIONS; SPINAL CORDS; THERAPEUTIC MOLECULES;

CELL CULTURE;

RATTUS;

DNA; GLUCAN; PULLULAN; SPERMINE;

ADIPOSE TISSUE; ANIMAL; ARTICLE; BONE MARROW CELL; CELL DEATH; CELL DIFFERENTIATION; CELL SURVIVAL; CYTOLOGY; GENETIC ENGINEERING; GENETIC TRANSFECTION; HUMAN; INTRACELLULAR SPACE; MESENCHYMAL STEM CELL; METABOLISM; METHODOLOGY; PATHOLOGY; RAT; SERUM; SPINAL CORD; STROMA CELL; TRANSPLANTATION; TRANSPORT AT THE CELLULAR LEVEL; WISTAR RAT;

ADIPOSE TISSUE; ANIMALS; BIOLOGICAL TRANSPORT; BONE MARROW CELLS; CELL DEATH; CELL DIFFERENTIATION; CELL SURVIVAL; DNA; GENETIC ENGINEERING; GLUCANS; HUMANS; INTRACELLULAR SPACE; MESENCHYMAL STEM CELLS; RATS; RATS, WISTAR; SERUM; SPERMINE; SPINAL CORD; STROMAL CELLS; TRANSFECTION;

EID: 79551521435     PISSN: 19373384     EISSN: 19373392     Source Type: Journal    
DOI: 10.1089/ten.tec.2010.0120     Document Type: Article

References (56)

1. Kumar, S., Chanda, D., and Ponnazhagan, S. Therapeutic potential of genetically modified mesenchymal stem cells. Gene Ther 15, 711, 2008.
2. Jäderstad, J., Jä derstad, L.M., Li, J., Chintawar, S., Salto, C., Pandolfo, M., Ourednik, V., Teng, Y.D., Sidman, R.L., Arenas, E., Snyder, E.Y., and Herlenius, E. Communication via gap junctions underlies early functional and beneficial interactions between grafted neural stem cells and the host. Proc Natl Acad Sci USA 107, 5184, 2010.
3. Giudice, A., and Trounson, A. Genetic modification of human embryonic stem cells for derivation of target cells. Cell Stem Cell 2, 422, 2008.
4. Phillips, M.I., and Tang, Y.L. Genetic modification of stem cells for transplantation. Adv Drug Deliv Rev 60, 160, 2008.
5. Tey, S.K., and Brenner, M.K. The continuing contribution of gene marking to cell and gene therapy. Mol Ther 15, 666, 2007.
6. Kimelman, N., Pelled, G., Helm, G.A., Huard, J., Schwarz, E.M., and Gazit, D. Review: gene- and stem cell-based therapeutics for bone regeneration and repair. Tissue Eng 13, 1135, 2007.
7. Papapetrou, E.P., Zoumbos, N.C., and Athanassiadou, A. Genetic modification of hematopoietic stem cells with non-viral systems: past progress and future prospects. Gene Ther 12, S118, 2005.
8. Thakor, D.K., Teng, Y.D., and Tabata, Y. Neuronal gene delivery by negatively charged pullulan-spermine/DNA anioplexes. Biomaterials 30, 1815, 2009.
9. Wagner, W., and Ho, A.D. Mesenchymal stem cell preparations-comparing apples and oranges. Stem Cell Rev 3, 239, 2007.
10. Takamoto, T., Hiraoka, Y., and Tabata, Y. Enhanced proliferation and osteogenic differentiation of rat mesenchymal stem cells in collagen sponge reinforced with different poly(ethylene terephthalate) fibers. J Biomater Sci Polym Ed 18, 865, 2007.
11. Kimura, Y., Ozeki, M., Inamoto, T., and Tabata, Y. Adipose tissue engineering based on human preadipocytes combined with gelatin microspheres containing basic fibroblast growth factor. Biomaterials 24, 2513, 2003.
12. Pfander, D., Cramer, T., Schipani, E., and Johnson, R.S. HIF-1alpha controls extracellular matrix synthesis by epiphyseal chondrocytes. J Cell Sci 116, 1819, 2003.
13. Incani, V., Tunis, E., Clements, B.A., Olson, C., Kucharski, C., Lavasanifar, A., and Uludag, H. Palmitic acid substitution on cationic polymers for effective delivery of plasmid DNA to bone marrow stromal cells. J Biomed Mater ResA81, 493, 2007.
14. Hoelters, J., Ciccarella, M., Drechsel, M., Geissler, C., Gü l-kan, H., Böcker, W., Schieker, M., Jochum, M., and Neth, P. Nonviral genetic modification mediates effective transgene expression and functional RNA interference in human mesenchymal stem cells. J Gene Med 7, 718, 2005.
15. Clements, B.A., Bai, J., Kucharski, C., Farrell, L.L., Lavasa-nifar, A., Ritchie, B., Ghahary, A., and Uludag, H. RGD conjugation to polyethyleneimine does not improve DNA delivery to bone marrow stromal cells. Biomacromolecules 7, 1481, 2006.
16. Ahn, H.H., Lee, J.H., Kim, K.S., Lee, J.Y., Kim, M.S., Khang, G., Lee, I.W., and Lee, H.B. Polyethyleneimine-mediated gene delivery into human adipose derived stem cells. Biomaterials 29, 2415, 2008.
17. Jo, J., Ikai, T., Okazaki, A., Yamamoto, M., Hirano, Y., and Tabata, Y. Expression profile of plasmid DNA by spermine derivatives of pullulan with different extents of spermine introduced. J Control Release 118, 389, 2007.
18. Jo, J., Nagaya, N., Miyahara, Y., Kataoka, M., Harada-Shiba, M., Kangawa, K., and Tabata, Y. Transplantation of genetically engineered mesenchymal stem cells improves cardiac function in rats with myocardial infarction: benefit of a novel nonviral vector, cationized dextran. Tissue Eng 13, 313, 2007.
19. Tanaka, T., Hamano, S., Fujishima, Y., and Kaneo, Y. Uptake of pullulan in cultured rat liver parenchymal cells. Biol Pharm Bull 28, 560, 2005.
20. Wang, L., and MacDonald, R.C. Effects of microtubule-depolymerizing agents on the transfection of cultured vascular smooth muscle cells: enhanced expression with free drug and especially with drug-gene lipoplexes. Mol Ther 9, 729, 2004.
21. Nair, R.R., Rodgers, J.R., and Schwarz, L.A. Enhancement of transgene expression by combining glucocorticoids and anti-mitotic agents during transient transfection using DNA-cationic liposomes. Mol Ther 5, 455, 2002.
22. Okazaki, A., Jo, J., and Tabata, Y. A reverse transfection technology to genetically engineer adult stem cells. Tissue Eng 13, 245, 2007.
23. Milligan, E.D., Sloane, E.M., Langer, S.J., Hughes, T.S., Je-kich, B.M., Frank, M.G., Mahoney, J.H., Levkoff, L.H., Maier, S.F., Cruz, P.E., Flotte, T.R., Johnson, K.W., Mahoney, M.M., Chavez, R.A., Leinwand, L.A., and Watkins, L.R. Repeated intrathecal injections of plasmid DNA encoding interleukin-10 produce prolonged reversal of neuropathic pain. Pain 126, 294, 2006.
24. Yang, F., Green, J.J., Dinio, T., Keung, L., Cho, S.W., Park, H., Langer, R., and Anderson, D.G. Gene delivery to human adult and embryonic cell-derived stem cells using biodegradable nanoparticulate polymeric vectors. Gene Ther 16, 533, 2009.
25. Clements, B.A., Incani, V., Kucharski, C., Lavasanifar, A., Ritchie, B., and Uludag?, H. A comparative evaluation of poly-L-lysine-palmitic acid and Lipofectamine 2000 for plasmid delivery to bone marrow stromal cells. Biomaterials 28, 4693, 2007.
26. Dokka, S., Toledo, D., Shi, X., Castranova, V., and Rojana-sakul, Y. Oxygen radical-mediated pulmonary toxicity induced by some cationic liposomes. Pharm Res 17, 521, 2000.
27. Hunter, A.C. Molecular hurdles in polyfectin design and mechanistic background to polycation induced cytotoxicity. Adv Drug Deliv Rev 2, 1523, 2006.
28. Werkmeister, J.A., Hewish, D.R., Kirkpatrick, A., and Rivett, D.E. Sequence requirements for the activity of membrane-active peptides. J Pept Res 60, 232, 2002.
29. Thomas, M., and Klibanov, A.M. Non-viral gene therapy: polycation-mediated DNA delivery. Appl Microbiol Biotechnol 62, 27, 2003.
30. Nishikawa, M., and Huang, L. Nonviral vectors in the new millennium: delivery barriers in gene transfer. Hum Gene Ther 12, 861, 2001.
31. Corsi, K., Chellat, F., Yahia, L., and Fernandes, J.C. Me-senchymal stem cells, MG63 and HEK293 transfection using chitosan-DNA nanoparticles. Biomaterials 24, 1255, 2003.
32. Chamberlain, G., Fox, J., Ashton, B., and Middleton, J. Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 25, 2739, 2007.
33. Brinchmann, J.E. Expanding autologous multipotent mes-enchymal bone marrow stromal cells. J Neurol Sci 265, 127, 2008.
34. Vacanti, V., Kong, E., Suzuki, G., Sato, K., Canty, J.M., and Lee, T. Phenotypic changes of adult porcine mesenchymal stem cells induced by prolonged passaging in culture. J Cell Physiol 205, 194, 2005.
35. Vickers, S.M., Gotterbarm, T., and Spector, M. Cross-linking affects cellular condensation and chondrogenesis in type II collagen-GAG scaffolds seeded with bone marrow-derived mesenchymal stem cells. J Orthop Res 28, 1184, 2010.
36. Corish, P., and Tyler-Smith, C. Attenuation of green fluorescent protein half-life in mammalian cells. Protein Eng 12, 1035, 1999.
37. Gill, D.R., Smyth, S.E., Goddard, C.A., Pringle, I.A., Higgins, C.F., Colledge, W.H., and Hyde, S.C. Increased persistence of lung gene expression using plasmids containing the ubi-quitin C or elongation factor 1alpha promoter. Gene Ther 8, 1539, 2001.
38. Alexopoulou, A.N., Couchman, J.R., and Whiteford, J.R. The CMV early enhancer/chicken beta actin (CAG) promoter can be used to drive transgene expression during the differentiation of murine embryonic stem cells into vascular progenitors. BMC Cell Biol 9, 2, 2008.
39. Yoon, S.H., Shim, Y.S., Park, Y.H., Chung, J.K., Nam, J.H., Kim, M.O., Park, H.C., Park, S.R., Min, B.H., Kim, E.Y., Choi, B.H., Park, H., and Ha, Y. Complete spinal cord injury treatment using autologous bone marrow cell transplantation and bone marrow stimulation with granulocyte macrophage-colony stimulating factor: phase I/II clinical trial. Stem Cells 25, 2066, 2007.
40. Syková, E., Homola, A., Mazanec, R., Lachmann, H., Kon-rádová, S.L., Kobylka, P., Pádr, R., Neuwirth, J., Komrska, V., Vávra, V., Stuĺ k, J., and Bojar, M. Autologous bone marrow transplantation in patients with subacute and chronic spinal cord injury. Cell Transplant 15, 675, 2006.
41. Callera, F., and do Nascimento, R.X. Delivery of autologous bone marrow precursor cells into the spinal cord via lumbar puncture technique in patients with spinal cord injury: a preliminary safety study. Exp Hematol 34, 130, 2006.
42. Hayase, M., Kitada, M., Wakao, S., Itokazu, Y., Nozaki, K., Hashimoto, N., Takagi, Y., and Dezawa, M. Committed neural progenitor cells derived from genetically modified bone marrow stromal cells ameliorate deficits in a rat model of stroke. J Cereb Blood Flow Metab 29, 1409, 2009.
43. Nagane, K., Kitada, M., Wakao, S., Dezawa, M., and Tabata, Y. Practical induction system for dopamine-producing cells from bone marrow stromal cells using spermine-pullulan-mediated reverse transfection method. Tissue Eng Part A 15, 1655, 2009.
44. Prockop, D.J. Repair of tissues by adult stem/progenitor cells (MSCs): controversies, myths, and changing paradigms. Mol Ther 17, 939, 2009.
45. Teng, Y.D., Lavik, E.B., Qu, X., Park, K.I., Ourednik, J., Zurakowski, D., Langer, R., and Snyder, E.Y. Functional recovery following traumatic spinal cord injury mediated by a unique polymer scaffold seeded with neural stem cells. Proc Natl Acad Sci USA 99, 3024, 2002.
46. Mitsui, T., Fischer, I., Shumsky, J.S., and Murray, M. Transplants of fibroblasts expressing BDNF and NT-3 promote recovery of bladder and hindlimb function following spinal contusion injury in rats. Exp Neurol 194, 410, 2005.
47. Nakahara, Y., Gage, F.H., and Tuszynski, M.H. Grafts of fibroblasts genetically modified to secrete NGF, BDNF, NT-3, or basic FGF elicit differential responses in the adult spinal cord. Cell Transplant 5, 191, 1996.
48. Duplan, H., Li, R.Y., Vue, C., Zhou, H., Emorine, L., Herman, J.P., Tafani, M., Lazorthes, Y., and Eaton, M.J. Grafts of immortalized chromaffin cells bio-engineered to improve met-enkephalin release also reduce formalin-evoked c-fos expression in rat spinal cord. Neurosci Lett 370, 1, 2004.
49. Castellanos, D.A., Tsoulfas, P., Frydel, B.R., Gajavelli, S., Bes, J.C., and Sagen, J. TrkC overexpression enhances survival and migration of neural stem cell transplants in the rat spinal cord. Cell Transplant 11, 297, 2002.
50. Parr, A.M., Tator, C.H., and Keating, A. Bone marrow-derived mesenchymal stromal cells for the repair of central nervous system injury. Bone Marrow Transplant 40, 609, 2007.
51. Walker, P.A., Harting, M.T., Jimenez, F., Shah, S.K., Pati, S., Dash, P.K., and Cox, C.S. Direct intrathecal implantation of mesenchymal stromal cells leads to enhanced neuroprotec-tion via an NFkappaB mediated increase in interleukin 6 (IL-6) production. Stem Cells Dev 19, 867, 2010.
52. Rivera, F.J., Couillard-Despres, S., Pedre, X., Ploetz, S., Caioni, M., Lois, C., Bogdahn, U., and Aigner, L. Mesench-ymal stem cells instruct oligodendrogenic fate decision on adult neural stem cells. Stem Cells 24, 2209, 2006.
53. Munoz, J.R., Stoutenger, B.R., Robinson, A.P., Spees, J.L., and Prockop, D.J. Human stem/progenitor cells from bone marrow promote neurogenesis of endogenous neural stem cells in the hippocampus of mice. Proc Natl Acad Sci USA 102, 18171, 2005.
54. Ohtaki, H., Ylostalo, J.H., Foraker, J.E., Robinson, A.P., Reger, R.L., Shioda, S., and Prockop, D.J. Stem/progenitor cells from bone marrow decrease neuronal death in global ischemia by modulation of inflammatory/immune responses. Proc Natl Acad Sci USA 105, 14638, 2008.
55. Lu, P., Jones, L.L., and Tuszynski, M.H. BDNF-expressing marrow stromal cells support extensive axonal growth at sites of spinal cord injury. Exp Neurol 191, 344, 2005.
56. Hollis, E.R., 2nd, Lu, P., Blesch, A., and Tuszynski, M.H. IGF-I gene delivery promotes corticospinal neuronal survival but not regeneration after adult CNS injury. Exp Neurol 215, 53, 2009.